News
company
year
domain
Seres Therapeutics 11.07.2017
Black Duck Software 11.02.2017
Visterra 11.01.2017
Moderna 11.01.2017
Moderna 10.19.2017
Visterra 10.18.2017
2017
Seres Therapeutics Awarded Grant from CARB-X to Support Development of Microbiome Therapeutic Candidate
Synopsys to Enhance Software Integrity Platform with Acquisition of Black Duck Software
FDA Grants Fast Track Designation to Visterra’s VIS410 for Treatment of Hospitalized Patients with Influenza A
Moderna Announces New Collaboration with AstraZeneca to Co-Develop and Co-Commercialize Relaxin mRNA Therapeutic for Heart Failure
Moderna Named One of Global Biopharmaceutical Industry’s Top Employers in Science Magazine’s Annual Survey
Visterra Announces Research Collaboration, Exclusive License, and Option Agreement for Infectious Diseases with Vir Biotechnology